Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist

被引:25
|
作者
Ignar, DM
Andrews, JL
Jansen, M
Eilert, MM
Pink, HM
Lin, PY
Sherrill, RG
Szewczyk, JR
Conway, JG
机构
[1] GlaxoSmithKline, Dept Metab Dis, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Dept Mol Pharmacol, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA
关键词
melanocortin; TNF-alpha; alpha-MSH; melanocortin-1;
D O I
10.1016/S0196-9781(03)00127-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lack of specific pharmacological tools has impeded the evaluation of the role of each melanocortin receptor (MCR) subtype in the myriad physiological effects of melanocortins. 154N-5 is an octapeptide (MFRdWFKPV-NH2) that was first identified as an MC1R antagonist in Xenopus melanophores [J. Biol. Chem. 269 (1994) 29846]. In this manuscript, we show that 154N-5 is a specific agonist for human and murine MC1R. The peptide has negligible activity at MC3R and MC4R and is 25-fold less potent and a weak agonist at MC5R. 154N-5 was tested in both a cellular and an animal model of tumor necrosis factor-alpha (TNF-alpha) secretion. The inhibitory efficacy of 154N-5 on TNF-alpha secretion in both models was similar to the nonselective agonist NDP-alpha-melanocyte stimulating hormone (NDP-alphaMSH), thus, we conclude that inhibition of TNF-alpha secretion by melanocortin peptides is mediated by MC1R. 154N-5 is a valuable new tool for the evaluation of specific contribution of MC1R agonism to physiological and pathological processes. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:709 / 716
页数:8
相关论文
共 50 条
  • [21] Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT-7117), an Oral Melanocortin-1 Receptor Agonist
    Ogasawara, Akihito
    Ide, Ryosuke
    Inoue, Shinsuke
    Teng, Renli
    Kawaguchi, Atsuhiro
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 729 - 738
  • [22] The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans
    Mogil, JS
    Wilson, SG
    Chesler, EJ
    Rankin, AL
    Nemmani, KVS
    Lariviere, WR
    Groce, MK
    Wallace, MR
    Kaplan, L
    Staud, R
    Ness, TJ
    Glover, TL
    Stankova, M
    Mayorov, A
    Hruby, VJ
    Grisel, JE
    Fillingim, RB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) : 4867 - 4872
  • [23] Identification of melanocortin-1 receptor selective small molecule agonists
    Haskell-Luevano, C
    Rosenquist, A
    Souers, A
    Kong, K
    Ellman, J
    Cone, RD
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 243 - 244
  • [24] Conformationally constrained metallopeptide template for melanocortin-1 receptor.
    Shi, Y
    Cai, HZ
    Yang, WH
    Blood, C
    Shadiack, A
    Sharma, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1001 - U1001
  • [25] EXPRESSION OF MELANOCORTIN-1 RECEPTOR IN PERIAQUEDUCTAL GRAY-MATTER
    XIA, Y
    WIKBERG, JES
    CHHAJLANI, V
    NEUROREPORT, 1995, 6 (16) : 2193 - 2196
  • [26] PHARMACOKINETIC ANALYSIS IN RATS AND DOGS AFTER ORAL DOSING OF MELANOCORTIN-1 RECEPTOR AGONIST PL8177
    Dodd, John
    Makhlina, Marie
    Yang, Wei H.
    Koplowitz, Luana Pesco
    Koplowitz, Barry
    GASTROENTEROLOGY, 2021, 160 (06) : S327 - S328
  • [27] Color polymorphism in Plethodon cinereus: Mutations in the melanocortin-1 receptor
    Kimble, Danielle C.
    Hyatt, Carly
    Pytel, Barbara
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [28] Phenotypic expression of melanocortin-1 receptor mutations in black Jamaicans
    McKenzie, CA
    Harding, RM
    Tomlinson, JB
    Ray, AJ
    Wakamatsu, K
    Rees, JL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (01) : 207 - 208
  • [29] An overview of benefits and risks of chronic melanocortin-1 receptor activation
    Boehm, M.
    Robert, C.
    Malhotra, S.
    Clement, K.
    Farooqi, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [30] The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation
    Abdel-Malek, Z
    Scott, MC
    Suzuki, I
    Tada, A
    Im, S
    Lamoreux, L
    Ito, S
    Barsh, G
    Hearing, VJ
    PIGMENT CELL RESEARCH, 2000, 13 : 156 - 162